Aessoa Global Hyaluronic Acid Dermal Filler with Lidocaine 1ml is a hyaluronic acid-based filler developed for practitioners requiring precision correction of superficial to mid-dermal lines, alongside subtle lip contour definition. The formulation contains 24 mg/ml of monophasic cross-linked hyaluronic acid, providing a balance between softness and structural support, making it suitable for delicate facial areas where control and even distribution are essential. This product is commonly selected for the treatment of fine lines associated with early signs of ageing, including periorbital wrinkles and superficial facial lines. Its hydrophilic nature supports skin hydration, contributing to improved skin texture in treated areas without excessive projection or rigidity. Aessoa Global includes 0.3% lidocaine to support patient comfort during injection. The controlled viscosity range of approximately 100–200 Pa·s allows predictable handling characteristics, helping practitioners achieve smooth placement with reduced risk of product irregularities when used in accordance with recommended protocols. Designed for mid-dermal injection, Aessoa Global is positioned as a versatile filler for practitioners seeking subtle, natural-looking correction rather than volumisation. It is supplied in a 1.0 ml pre-filled syringe and is intended for use by trained and licensed aesthetic professionals only. How It Works The cross-linked hyaluronic acid integrates into the dermal tissue, where it attracts and retains water molecules. This supports soft tissue filling and hydration in superficial treatment areas. The monophasic structure promotes even distribution within the dermis, while lidocaine assists in reducing procedural discomfort. Key Benefits Supports correction of superficial and fine facial lines Contributes to improved skin hydration and texture Allows refined lip contour definition without excessive volume Predictable handling and smooth extrusion Includes lidocaine to support patient comfort